1. Home
  2. CYTK vs DJT Comparison

CYTK vs DJT Comparison

Compare CYTK & DJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • DJT
  • Stock Information
  • Founded
  • CYTK 1997
  • DJT 2021
  • Country
  • CYTK United States
  • DJT United States
  • Employees
  • CYTK N/A
  • DJT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • DJT Computer Software: Programming Data Processing
  • Sector
  • CYTK Health Care
  • DJT Technology
  • Exchange
  • CYTK Nasdaq
  • DJT Nasdaq
  • Market Cap
  • CYTK 5.6B
  • DJT 5.0B
  • IPO Year
  • CYTK 2004
  • DJT N/A
  • Fundamental
  • Price
  • CYTK $34.36
  • DJT $18.19
  • Analyst Decision
  • CYTK Buy
  • DJT
  • Analyst Count
  • CYTK 14
  • DJT 0
  • Target Price
  • CYTK $70.92
  • DJT N/A
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • DJT 8.8M
  • Earning Date
  • CYTK 08-07-2025
  • DJT 08-08-2025
  • Dividend Yield
  • CYTK N/A
  • DJT N/A
  • EPS Growth
  • CYTK N/A
  • DJT N/A
  • EPS
  • CYTK N/A
  • DJT N/A
  • Revenue
  • CYTK $19,218,000.00
  • DJT $3,669,500.00
  • Revenue This Year
  • CYTK $34.81
  • DJT N/A
  • Revenue Next Year
  • CYTK $643.79
  • DJT N/A
  • P/E Ratio
  • CYTK N/A
  • DJT N/A
  • Revenue Growth
  • CYTK 412.21
  • DJT N/A
  • 52 Week Low
  • CYTK $29.31
  • DJT $11.75
  • 52 Week High
  • CYTK $61.38
  • DJT $54.68
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 56.37
  • DJT 38.39
  • Support Level
  • CYTK $32.66
  • DJT $17.17
  • Resistance Level
  • CYTK $34.34
  • DJT $18.33
  • Average True Range (ATR)
  • CYTK 1.33
  • DJT 0.83
  • MACD
  • CYTK 0.21
  • DJT 0.05
  • Stochastic Oscillator
  • CYTK 76.45
  • DJT 31.29

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DJT Trump Media & Technology Group Corp. Common Stock

Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.

Share on Social Networks: